Metformin (MFM)
Metformin is an oral antidiabetic drug in the biguanide class. It is the first-line drug of choice for the treatment of type 2 diabetes, in particular, in overweight and obese people and those with normal kidney function. Its use in gestational diabetes has been limited by safety concerns. It is also used in the treatment of polycystic ovary syndrome, and has been investigated for other diseases where insulin resistance may be an important factor. Metformin works by suppressing glucose production by the liver. Metformin is the only antidiabetic drug that has been conclusively shown to prevent the cardiovascular complications of diabetes. It helps reduce LDL cholesterol and triglyceride levels, and is not associated with weight gain. Metformin causes few adverse effects when prescribed appropriately (the most common is gastrointestinal upset) and has been associated with a low risk of hypoglycemia.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Metformin (MFM) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Metformin (MFM) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Metformin (MFM) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Metformin (MFM) CLIA Kit Customized Service Offer
n/a ELISA Kit for Metformin (MFM) ELISA Kit Customized Service Offer